Advertisement
Screener

GEVO, INC. (GEVO) Net Income (Loss) Available to Common Stockholders, Diluted

GEVO, INC. Net Income (Loss) Available to Common Stockholders, Diluted

GEVO, INC. (GEVO) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$21.73 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-13.

Financial Statements › Income Statement › Net Income

us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2025-05-13

  • GEVO, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2025-03-31 was -$21.73M.
  • GEVO, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2024-12-31 was -$18.07M.
  • GEVO, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2024-09-30 was -$21.16M.
  • GEVO, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2024-06-30 was -$21.00M.
  • GEVO, INC. net income (loss) available to common stockholders, diluted for fiscal 2024 was -$79.10M.
  • GEVO, INC. net income (loss) available to common stockholders, diluted for fiscal 2023 was -$66.22M.
  • GEVO, INC. net income (loss) available to common stockholders, diluted for fiscal 2022 was -$98.01M.
  • GEVO, INC. net income (loss) available to common stockholders, diluted for fiscal 2021 was -$59.20M.
Period endNet Income (Loss) Available to Common Stockholders, Diluted 3 monthNet Income (Loss) Available to Common Stockholders, Diluted 6 monthNet Income (Loss) Available to Common Stockholders, Diluted 9 monthNet Income (Loss) Available to Common Stockholders, Diluted 12 month
2025-03-31-$21.73M
10-Q · filed 2025-05-13
-$39.80M
derived: sum of 2 quarters · filed 2025-05-13
-$60.95M
derived: sum of 3 quarters · filed 2025-05-13
-$81.95M
derived: sum of 4 quarters · filed 2025-05-13
2024-12-31-$18.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27
-$39.22M
derived: sum of 2 quarters · filed 2025-03-27
-$60.23M
derived: sum of 3 quarters · filed 2025-03-27
-$79.10M
10-K · filed 2025-03-27
2024-09-30-$21.16M
10-Q · filed 2024-11-07
-$42.16M
derived: sum of 2 quarters · filed 2024-11-07
-$61.03M
10-Q · filed 2024-11-07
-$79.51M
derived: sum of 4 quarters · filed 2025-05-13
2024-06-30-$21.00M
10-Q · filed 2024-08-08
-$39.88M
10-Q · filed 2024-08-08
-$58.35M
derived: sum of 3 quarters · filed 2025-05-13
-$74.05M
derived: sum of 4 quarters · filed 2025-05-13
2024-03-31-$18.88M
10-Q · filed 2025-05-13
-$37.35M
derived: sum of 2 quarters · filed 2025-05-13
-$53.05M
derived: sum of 3 quarters · filed 2025-05-13
-$67.47M
derived: sum of 4 quarters · filed 2025-05-13
2023-12-31-$18.48M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27
-$34.18M
derived: sum of 2 quarters · filed 2025-03-27
-$48.60M
derived: sum of 3 quarters · filed 2025-03-27
-$66.22M
10-K · filed 2025-03-27
2023-09-30-$15.70M
10-Q · filed 2024-11-07
-$30.12M
derived: sum of 2 quarters · filed 2024-11-07
-$47.74M
10-Q · filed 2024-11-07
-$73.13M
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30-$14.42M
10-Q · filed 2024-08-08
-$32.04M
10-Q · filed 2024-08-08
-$57.42M
derived: sum of 3 quarters · filed 2024-08-08
-$101.21M
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31-$17.62M
10-Q · filed 2024-05-02
-$43.01M
derived: sum of 2 quarters · filed 2024-05-02
-$86.79M
derived: sum of 3 quarters · filed 2024-05-02
-$99.95M
derived: sum of 4 quarters · filed 2024-05-02
2022-12-31-$25.39M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07
-$69.17M
derived: sum of 2 quarters · filed 2024-03-07
-$82.33M
derived: sum of 3 quarters · filed 2024-03-07
-$98.01M
10-K · filed 2024-03-07
2022-09-30-$43.79M
10-Q · filed 2023-11-14
-$56.95M
derived: sum of 2 quarters · filed 2023-11-14
-$72.62M
10-Q · filed 2023-11-14
-$89.13M
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30-$13.16M
10-Q · filed 2023-08-10
-$28.83M
10-Q · filed 2023-08-10
-$45.35M
derived: sum of 3 quarters · filed 2023-08-10
-$59.73M
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31-$15.67M
10-Q · filed 2023-05-10
-$32.19M
derived: sum of 2 quarters · filed 2023-05-10
-$46.57M
derived: sum of 3 quarters · filed 2023-05-10
-$64.82M
derived: sum of 4 quarters · filed 2023-05-10
2021-12-31-$16.51M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09
-$30.89M
derived: sum of 2 quarters · filed 2023-03-09
-$49.15M
derived: sum of 3 quarters · filed 2023-03-09
-$59.20M
10-K · filed 2023-03-09
2021-09-30-$14.38M
10-Q · filed 2022-11-08
-$32.63M
derived: sum of 2 quarters · filed 2022-11-08
-$42.69M
10-Q · filed 2022-11-08
2021-06-30-$18.25M
10-Q · filed 2022-08-08
-$28.31M
10-Q · filed 2022-08-08
2021-03-31-$10.06M
10-Q · filed 2022-05-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
Alto Ingredients, Inc. (ALTO)United States$0.289B8.52
FutureFuel Corp. (FF)United States$0.225B-6.53
Comstock Inc. (LODE)United States$0.195B-5.19
XCF Global, Inc. (SAFX)United States$0.171B-2.86
CODEXIS, INC. (CDXS)United States$0.151B-6.68
AEMETIS, INC (AMTX)United States$0.128B-1.95
LanzaTech Global, Inc. (LNZA)United States$0.078B0.52
TOMI Environmental Solutions, Inc. (TOMZ)United States$0.012B
Westlake Chemical Partners LP (WLKP)United States$0.754B2.35
Green Plains Inc. (GPRE)United States$1.054B8.70